Payment overview · 2025
General Payments
$67.23
4 reported records · 1 companies
Healthcare provider profile · identity verified
David M Uhall, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · KENT, OH · NPI 1336127794
Verified facts
What the public records show
CMS Open Payments records show David M Uhall, M.D. received $67.23 in general payments during 2025 across 4 reported records.
Lilly USA, LLC accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Mounjaro.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 65 claims for Jardiance by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 25 claims for Mounjaro by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 80 claims for Trulicity by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $67.23 | 100.0% | 4 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $67.23 | 4 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| MOUNJARO Normalized: mounjaro |
Drug | Lilly USA, LLC | $67.23 | 4 | 2025 |
Source payment records
|
|||||
| ZEPBOUND Normalized: zepbound |
Drug | Lilly USA, LLC | $67.23 | 4 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| MOUNJARO mounjaro |
2025 | Mounjaro | 2024 | 25 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
65 | 17 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | MOUNJARO open payments reported associated product |
CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455 |
Mounjaro · 2024 Exact normalized brand match · 1 Part D row |
25 | suppressed by CMS |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | TRULICITY open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601 |
Trulicity · 2024 Exact normalized brand match · 1 Part D row |
80 | 12 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 755 | 202 |
| Amlodipine Besylate | Amlodipine Besylate | 398 | 109 |
| Gabapentin | Gabapentin | 371 | 94 |
| Eliquis | Apixaban | 362 | 65 |
| Levothyroxine Sodium | Levothyroxine Sodium | 358 | 92 |
| Losartan Potassium | Losartan Potassium | 346 | 100 |
| Lisinopril | Lisinopril | 342 | 81 |
| Furosemide | Furosemide | 316 | 95 |
| Metoprolol Tartrate | Metoprolol Tartrate | 300 | 90 |
| Pantoprazole Sodium | Pantoprazole Sodium | 297 | 94 |
| Sertraline Hcl | Sertraline Hcl | 294 | 73 |
| Tramadol Hcl | Tramadol Hcl | 272 | 52 |
| Hydrochlorothiazide | Hydrochlorothiazide | 263 | 69 |
| Omeprazole | Omeprazole | 224 | 77 |
| Tamsulosin Hcl | Tamsulosin Hcl | 219 | 67 |
| Metoprolol Succinate | Metoprolol Succinate | 218 | 64 |
| Escitalopram Oxalate | Escitalopram Oxalate | 216 | 49 |
| Trazodone Hcl | Trazodone Hcl | 216 | 56 |
| Carvedilol | Carvedilol | 210 | 41 |
| Doxycycline Hyclate | Doxycycline Hyclate | 176 | 113 |
| Potassium Chloride | Potassium Chloride | 169 | 45 |
| Clopidogrel | Clopidogrel Bisulfate | 153 | 47 |
| Metformin Hcl | Metformin Hcl | 151 | 48 |
| Prednisone | Prednisone | 148 | 87 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 147 | 46 |
| Fluticasone Propionate | Fluticasone Propionate | 142 | 53 |
| Famotidine | Famotidine | 131 | 31 |
| Pravastatin Sodium | Pravastatin Sodium | 125 | 29 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 119 | 54 |
| Mirtazapine | Mirtazapine | 117 | 32 |
| Simvastatin | Simvastatin | 116 | 37 |
| Duloxetine Hcl | Duloxetine Hcl | 111 | 32 |
| Tizanidine Hcl | Tizanidine Hcl | 107 | 46 |
| Lorazepam | Lorazepam | 101 | 28 |
| Meloxicam | Meloxicam | 99 | 40 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 97 | 20 |
| Glimepiride | Glimepiride | 94 | 26 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 87 | 21 |
| Donepezil Hcl | Donepezil Hcl | 83 | 27 |
| Trulicity | Dulaglutide | 80 | 12 |
| Allopurinol | Allopurinol | 77 | 26 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 67 | 16 |
| Jardiance | Empagliflozin | 65 | 17 |
| Ropinirole Hcl | Ropinirole Hcl | 65 | 13 |
| Alendronate Sodium | Alendronate Sodium | 64 | 22 |
| Azithromycin | Azithromycin | 64 | 45 |
| Finasteride | Finasteride | 64 | 19 |
| Nystatin | Nystatin | 64 | 34 |
| Citalopram Hbr | Citalopram Hydrobromide | 61 | 15 |
| Hydralazine Hcl | Hydralazine Hcl | 60 | 12 |
| Divalproex Sodium | Divalproex Sodium | 59 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 58 | 20 |
| Spironolactone | Spironolactone | 54 | 22 |
| Cephalexin | Cephalexin | 53 | 23 |
| Entresto | Sacubitril/Valsartan | 53 | 12 |
| Xarelto | Rivaroxaban | 52 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 50 | suppressed |
| Clonazepam | Clonazepam | 50 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 50 | 15 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 49 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 49 | 26 |
| Cefdinir | Cefdinir | 47 | 41 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 47 | 24 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 47 | 13 |
| Lamotrigine | Lamotrigine | 47 | suppressed |
| Alprazolam | Alprazolam | 46 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 46 | 15 |
| Memantine Hcl | Memantine Hcl | 45 | 12 |
| Levetiracetam | Levetiracetam | 44 | suppressed |
| Lovastatin | Lovastatin | 43 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 42 | 12 |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 41 | 41 |
| Bumetanide | Bumetanide | 41 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 40 | 11 |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 40 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 40 | 14 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 39 | suppressed |
| Synthroid | Levothyroxine Sodium | 38 | 11 |
| Farxiga | Dapagliflozin Propanediol | 37 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 37 | 15 |
| Insulin Lispro | Insulin Lispro | 36 | 12 |
| Oxycodone Hcl | Oxycodone Hcl | 36 | 24 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 35 | 11 |
| Fluconazole | Fluconazole | 34 | 21 |
| Januvia | Sitagliptin Phosphate | 34 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 34 | 17 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 33 | suppressed |
| Bupropion Xl | Bupropion Hcl | 33 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 33 | 11 |
| Ezetimibe | Ezetimibe | 32 | suppressed |
| Jantoven | Warfarin Sodium | 32 | suppressed |
| Olanzapine | Olanzapine | 32 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 32 | 14 |
| Clonidine Hcl | Clonidine Hcl | 31 | suppressed |
| Hydrocortisone | Hydrocortisone | 31 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 31 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 30 | 16 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 30 | 22 |
| Naproxen | Naproxen | 30 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 30 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 29 | suppressed |
| Latanoprost | Latanoprost | 29 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 29 | 12 |
| Quetiapine Fumarate | Quetiapine Fumarate | 29 | 13 |
| Sodium Chloride | 0.9 % Sodium Chloride | 29 | 17 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 28 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 28 | 17 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 28 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 28 | suppressed |
| Atenolol | Atenolol | 27 | suppressed |
| Ketoconazole | Ketoconazole | 27 | 11 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 27 | 11 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 26 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 26 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 26 | suppressed |
| Celecoxib | Celecoxib | 25 | suppressed |
| Mounjaro | Tirzepatide | 25 | suppressed |
| Ondansetron Odt | Ondansetron | 25 | 19 |
| Ibuprofen | Ibuprofen | 24 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 24 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 24 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 24 | 24 |
| Torsemide | Torsemide | 24 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 24 | 11 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 23 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 23 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 22 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 22 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 22 | 11 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 22 | 15 |
| Amiodarone Hcl | Amiodarone Hcl | 21 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 21 | suppressed |
| Verapamil Er | Verapamil Hcl | 21 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 20 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 20 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 20 | suppressed |
| Pregabalin | Pregabalin | 20 | suppressed |
| Brilinta | Ticagrelor | 19 | suppressed |
| Carbamazepine | Carbamazepine | 19 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 19 | 11 |
| Paroxetine Hcl | Paroxetine Hcl | 19 | suppressed |
| Valsartan | Valsartan | 19 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 18 | 12 |
| Creon | Lipase/Protease/Amylase | 18 | suppressed |
| Linzess | Linaclotide | 18 | suppressed |
| Risperidone | Risperidone | 18 | suppressed |
| Topiramate | Topiramate | 18 | suppressed |
| Velphoro | Sucroferric Oxyhydroxide | 18 | suppressed |
| Diazepam | Diazepam | 17 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 17 | suppressed |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 17 | suppressed |
| Acyclovir | Acyclovir | 16 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 16 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 16 | 11 |
| Digoxin | Digoxin | 16 | suppressed |
| Glipizide | Glipizide | 16 | suppressed |
| Methylprednisolone | Methylprednisolone | 16 | 15 |
| Propranolol Hcl | Propranolol Hcl | 16 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 16 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 15 | suppressed |
| Lansoprazole | Lansoprazole | 15 | suppressed |
| Methimazole | Methimazole | 15 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 15 | suppressed |
| Ozempic | Semaglutide | 15 | suppressed |
| Ranolazine Er | Ranolazine | 15 | suppressed |
| Tradjenta | Linagliptin | 15 | suppressed |
| Cilostazol | Cilostazol | 14 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 14 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 14 | suppressed |
| Nitroglycerin | Nitroglycerin | 14 | suppressed |
| Semglee (Yfgn) Pen | Insulin Glargine-Yfgn | 14 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 14 | suppressed |
| Amantadine | Amantadine Hcl | 13 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 13 | suppressed |
| Metronidazole | Metronidazole | 13 | suppressed |
| Mupirocin | Mupirocin | 13 | suppressed |
| Vascepa | Icosapent Ethyl | 13 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 12 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 12 | suppressed |
| Klor-Con M20 | Potassium Chloride | 12 | suppressed |
| Levofloxacin | Levofloxacin | 12 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 12 | 11 |
| Methenamine Hippurate | Methenamine Hippurate | 12 | suppressed |
| Methotrexate | Methotrexate Sodium | 12 | suppressed |
| Ramipril | Ramipril | 12 | suppressed |
| Rivastigmine | Rivastigmine | 12 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Timolol Maleate | Timolol Maleate | 12 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 12 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 11 | suppressed |
| Estradiol | Estradiol | 11 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 11 | suppressed |
| Irbesartan | Irbesartan | 11 | suppressed |
| Lidocaine | Lidocaine | 11 | suppressed |
| Oxycontin | Oxycodone Hcl | 11 | suppressed |
| Rybelsus | Semaglutide | 11 | suppressed |
| Vancomycin Hcl-D5w | Vancomycin Hcl In 5 % Dextrose | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $67.23 · 4 records | Lilly USA, LLC | MOUNJARO, ZEPBOUND | 3 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Mounjaro play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Lilly USA, LLC?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error